Independently-tested CBD beverages had CBD content inconsistent with labels, says Leafreport

August 26, 2020

Leafreport has released the results of testing conducted by third party testing lab Canalysis Laboratories on CBD-infused beverages. The results were disappointing, as 81% of the products tested contained different levels of CBD than advertised.

Following up on a previous study of CBD content claims, Leafreport has released the results of testing conducted by third party testing lab Canalysis Laboratories on CBD-infused beverages. The results were disappointing, as 81% of the products tested contained different levels of CBD than advertised. Considering the popularity of functional foods and beverages overall, these results have negative implications for the CBD space.

The results varied widely, from products that contained less than the labeled CBD content, to products that contained more than the labeled content. Of all the products, only four were within 10% of the labeled CBD content. Of the 12 products that contained less CBD than advertised, one was within 20% of the labeled content, and nine differed from the labeled content by more than 30%. Two products contained no CBD at all.

Six products contained more CBD than stated on the label. Two of these were within 20% of the labeled CBD content, one was within 30% of the labeled content, and three contained more than 30% more CBD than stated on the label. And, unlike the first report, there was no positive association found between the company’s overall reputation and their test results.

Unfortunately, these results only add to the body of research showing inconsistency of CBD content throughout the CBD space. Several years of testing conducted by FDA, for example, showed CBD contents that did not match those advertised on the label.